Novo Nordisk CEO Defends Diversification Strategy – CEO NA Magazine
4 Articles
4 Articles
After Novo failed to convince skeptics, CEO Mike Doustdar is now speaking out. He does not believe that a falling share price is an indication of whether the company is moving in the right direction. Novo is focused on exceeding its own expectations, he says.
For Novo, it has been a tough day on the stock exchange, with the company holding a capital markets day throughout the day.
Novo Nordisk CEO defends diversification strategy – CEO NA Magazine
Speaking to reporters Tuesday after the company’s stock fell nearly 8%, Novo CEO Mike Doustdar defended his diversification strategy as the company mulls M&A opportunities amid increasing competition. “Let’s see where the gaps are, and let’s go out and see who has produced or is about to introduce better drugs than we are able to do on our own, and when that gap can be filled with M&A, we are actually quite interested about it.” “I think yesterd…
The morning after a capital markets day in which the stock fell 7.7 percent, Novo CEO Mike Doustdar acknowledges that more needs to be done to win back investor confidence. He said this in an interview with Bloomberg TV on Monday morning.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
